The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats

Acta Physiologica Hungarica

Volumn 99, Issue 1, 2012, Pages 61-73

  Olteanu, D ^a   Filip, A ^b   Muresan A ^a   Nagy, A ^b   Tabaran, F ^b   Moldovan, R ^a   Decea, N ^a   Catoi, C ^b   Clichici, S ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b USAMV   (Romania)

Author keywords

bile duct ligation; chitosan; dexamethasone; extrahepatic cholestasis; natural products; necro inflammatory score; NO; oxidative stress; Wistar rats

Indexed keywords

CHITOSAN; DEXAMETHASONE; MALONALDEHYDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HEPATITIS; LIVER INJURY; LIVER NECROSIS; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; CHITOSAN; CHOLESTASIS, EXTRAHEPATIC; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GLUTATHIONE; LIGATION; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84858953578     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.99.2012.1.7     Document Type: Article

References (29)

1. Ballatori N, Truong AT: Relation between biliary glutathione excretion and bile acid-independent bile flow. Am. J. Physiol. 256, G22-30 (1989)
2. Bergendi L, Benes L, Durackova Z, Ferencik M: Chemistry, physiology and pathology of free radicals. Life Sci. 65, 865-1874 (1999)
3. Bergmeyer HU, Scheibe P, Wahlefeld AW: Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24, 58-73 (1978) (Pubitemid 8262862)
4. Burt AD: Cellular and molecular aspect of hepatic fibrosis. J. Pathol. 170, 105-114 (1993) (Pubitemid 23192361)
5. Conti M, Moran PC, Levillain P: Improved fluorimetric determination of malondialdehyde. Clin. Chem. 37, 1273-1275 (1991)
6. Eken H, Ozturk H, Buyukbayram H: Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats. Gastroenterol. 12(33), 5379-5383 (2006) (Pubitemid 44501786)
7. Engin A, Dinçer S, Ercan SZ, Memic L, Bukan N, Bozkurt S: Regulation of fibrogenesis during the early phase of common bile duct obstruction. ANZ. J. Surg. 76, 645-648 (2006) (Pubitemid 43894120)
8. Esrefoglu M, Gul M, Emre MH, Polat A, Selimoglu MA: Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J. Gastroenterol. 11(13), 1951-1956 (2005) (Pubitemid 40520991)
9. Expert Panel on Enzymes: Committee on Standards (1FCC): Provisional recommendations (1975) on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate anilnotransferase. Clin. Chim. Acta. 70, F19-F42 (1976);
10. J. Clin. Chem. Clin. Biochem. 15, 39-51 (1977);
11. Clin. Chem. 23, 887-899 (1977)
12. Hu ML: Measurement of protein thiol groups and glutathion in plasma. Meth. Enzymol. 233, 380-384 (1994)
13. Jackson ER, Kilroy C, Joslin DL, Schomaker SJ, Pruimboom-Brees I, Amacher DE: The early effects of shortterm dexamethasone administration on hepatic and serum alanine aminotransferase in the rat. Drug. Chem. Toxicol. 31(4), 427-445 (2008)
14. Jeon YJ, Kim SK: Effect of chitooligosaccharides on acute oral toxicity. J. Chitin Chitosan 4, 115-120 (1999)
15. Karadeniz GÇ, Acikgoz S, Tekin IO, Tascýlar O, Dogan BG, Cömert M: Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis. Clinics 63, 531-540 (2008)
16. Kim ND, Moon JO, Slitt AL, Copple BL: Early growth response factor-1 is critical for cholestatic liver injury. Toxicological Sciences 90(2), 586-595 (2006)
17. Knodell RG et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431 (1981)
18. Mesbah DB, Bonnefont-Rousselot D, Frey-Fressart V, Moinard C, Delattre J, Vasson MP: Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation. Endocrine 10(3), 233-242 (1999) (Pubitemid 29372968)
19. Newton R: Molecular mechanisms of glucocorticoid action: What is important? Thorax 55, 603-613 (2000) (Pubitemid 30398277)
20. Oh HY, Namkoong S, Lee SJ, Por E, Kim CK, Billiar TR, Han JA et al: Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP. Cell Death Differ. 13, 512-523 (2006)
21. Perez MJ, Briz O: Bile-acid-induced cell injury and protection. World J. Gastroenterol. 15(14), 1677-1689 (2009)
22. Reznick AZ, Packer L: Oxidative damage to proteins spectrophotometric method for carbonyl assay. Meth. Enzymol. 233, 357-363 (1994)
23. Ryu BH: Antitumor and immunologic activity of chitosan extracted from shell of shrimp. J. Korea Soc. Food Nutr. 21, 154 (1992)
24. Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H et al: The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 96, 3368-3378 (2001) (Pubitemid 34016662)
25. Szasz G: A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin. Chem. 15, 124-136 (1969)
26. Tiao MM, Lin TK, Wang PW, Chen JB, Liou CW: The role of mitochondria in cholestatic liver injury. Chang Gung Med. J. 32, 346-353 (2009)
27. Titherage MA (1997): The enzymatic measurement of nitrate and nitrite. In: Methods in Molecular Biology 100 Nitric oxide Protocols. Humana Press. Inc., Totowa, pp. 83-91
28. Valkova M: Hepatic fibrogenesis. Bratisl. Lek. Listy 103(2), 76-85 (2002)
29. Yoshioka K, Mori A, Taniguchi K, Mutoh K: Cell proliferation activity of proliferating bile duct after bile duct ligation in rats. Vet. Pathol. 42, 382-385 (2005) (Pubitemid 40704834)